ClinicalTrials.gg
CompletedNCT07189273Updated Sep 23, 2025

Parents' Experiences of Administration Eye Drops

An observational study in Strabismus and Strabismus Surgery, sponsored by Uludag University. Completed at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2025-09-23.

Sponsored by Uludag University · Observational

Study type
Observational
Model
Family-based
Time perspective
Cross-sectional
Enrollment
13
Sex
All
01

Study summary

This study aimed to determine the experiences of parents of children aged 2-6 years who underwent strabismus surgery in eye drop administration and the cooperation of their children.

Methods: This semi-structured qualitative study was conducted with caregivers (n=13) of children aged 2-6 years who underwent strabismus surgery at the eye clinic of a university hospital in a province in the northwest of X. Data were collected through phone interviews held with children's parents on the third postoperative day. The interviews were audio-recorded, and the content of the recordings was analyzed using traditional content analysis.

02

Conditions studied

  • Strabismus
  • Strabismus Surgery

Browse trials for

Keywords

  • child
  • Strabismus surgery
  • Eye drop administration
  • Caregiver
03

In context

Strabismus

142 studies on the registry are indexed under Strabismus; 31 are open to participants now.

This study's enrollment of 13 is below the median of 96 across 54 observational studies indexed under Strabismus.

Browse Strabismus studies →

Lead sponsor

Uludag University is the lead sponsor of 149 studies on the registry; 42 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Parents of children aged 2-6 years who had never undergone eye surgery before and had strabismus surgery for the first time were included in this study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Parents of children aged 2-6 years
  • Children who had never undergone eye surgery before
  • Children who had strabismus surgery for the first time

Exclusion criteria

Exclusion Criteria:

  • Parents of children with physical and mental developmental retardation
  • Parents with cognitive disorders
  • Parents with hearing disorders
05

Study design

Observational model
Family-based
Time perspective
Cross-sectional
Enrollment
13 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Data collection form

    Development of Data Collection Form: A data collection form was developed by researchers based on the relevant literature. The form consisted of two sections. Section I: This section consisted of eight descriptive questions regarding the sociodemographic characteristics of children and their parents. Section II: This section consisted of seven semi-structured questions to evaluate the experiences of parents of children aged 2-6 years who underwent strabismus surgery when administering eye drops to their children, as well as the children's cooperation. The total number of questions in the form was 15.

    Time frame: Data was collected on the third day after the children were discharged.

07

Study locations

1 site
  • Bursa Uludag University
    Bursa, Nilüfer 16000, Turkey (Türkiye)
08

References and documents

Publications

  • Hirji N, Jones S, Thompson G. The causes of distress in Paediatric outpatients receiving dilating drops. Open J Ophthalmol. 2012;2:21.

Individual participant data

Plan to share: No — As this is a qualitative study, all data will be included in the article.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07189273
Lead sponsor
Uludag University
Responsible party
Yeliz Sapulu Alakan (Ph.D., Uludag University) — Principal investigator
First posted
Sep 23, 2025
Start date
Apr 5, 2024
Primary completion
Jul 20, 2024
Completion
Jul 21, 2024
Last update
Sep 23, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion